Dr Meike Kapp-Schwoerer

Rechtsanwältin (Lawyer) and Partner

Freiburg

Dr Meike Kapp-Schwoerer has been working as a lawyer in our Freiburg office since 2015 and became a partner in 2022. She advises clients primarily in the areas of life sciences (in particular medical device and pharmaceutical law), M&A, commercial law, international business law, as well as litigation and arbitration.

Languages

German
English
Italian

Contact

V-Card

Connect

Practices

Awards

JUVE Handbook of Commercial Law Firms 2025/26

Publications

Anforderungen an die Einberufung der Gesellschafterversammlung einer GmbH (Requirements for convening the shareholders’ meeting of a GmbH), 3. März 2026, fgvw.de, (together with Dr. Maximilian Fessel)

Wann handelt es sich um einen „Handelsvertretervertrag“ (und warum ist das relevant)? (When is it a “commercial agency agreement” (and why is it relevant)?, 30. Oktober 2025, fgvw.de, (together with Dr. Maximilian Fessel)

Diskussionspapier zur Zusammenarbeit zwischen Medizinprodukteherstellern und Benannten Stellen – Herausforderungen und Lösungsansätze (Discussion Paper on Collaboration between Medical Device Manufacturers and Notified Bodies – Challenges and Solutions), BIOPRO Baden-Württemberg GmbH (Hrsg.), 23. Juni 2025

Geschäftsführerpflichten bei wirtschaftlicher Neugründung einer GmbH (Duties of managing directors in the event of the economic reestablishment of a limited liability company), Deutscher AnwaltSpiegel, Issue 1, January 2024 (together with Maximilian Fessel)

Verträge müssen wasserdicht sein (Contracts must be watertight), MTDialog, 1/2021 (together with Dr. Hendrik Thies)

Haftung für Medizinprodukte – Gute Verträge und Versicherungen nötig (Liability for Medical Devices – Good Contracts and Insurance Necessary), MTDialog 10/2020, p. 50 f. (together with Dr. Hendrik Thies)

Medizinprodukte: Sonderzulassung nach strengen Regeln (Medical devices: Special approval according to strict rules), MTDialog 6/2020, p. 56 et seq. (together with Hendrik Thies)

Overview

Articles by Meike Kapp-Schwoerer

All articles

Firm News

17. June 2026

FGvW Advises AirSphere Shareholder on the Sale of All Shares to dormakaba

FGvW advised the shareholder of AirSphere GmbH on the sale of all shares to the dormakaba Group. AirSphere GmbH specializes in airport software. This primarily includes the “PaxControl” and “GateControl” software systems, which automate passenger check-in and handling, particularly at airports. dormakaba is a global provider of access and security solutions. The shareholder of AirSphere...

Reading time: 1 min

M&A

Legal Insights

12. May 2026

Updates in Medical Device Law – Update as of May 11, 2026

At the international level, the regulatory landscape for medical devices is constantly evolving. For all stakeholders, this means staying informed about new developments and adapting internal processes in a timely manner. On May 7, 2026, the European Commission, the Council, and the European Parliament agreed on a reform of the AI Regulation. In its press...

Reading time: 1 min

Medical device law, pharmaceutical law, healthcare

Legal Insights

3. December 2025

Updates on the Medical Device Regulation – The EU Takes Action (?)

At the international level, the regulatory landscape for medical devices is constantly changing. For all stakeholders, this means staying informed about new developments and adapting internal processes in a timely manner. With this brief “Update on the Medical Device Regulation,” we would like to summarize some important developments at the EU level. Several EUDAMED systems...

Reading time: 7 min

Medical device law, pharmaceutical law, healthcare